Interest of Maintenance Chemotherapy After Induction Treatment for

See also
Status	Clinical Trial	Phase
Completed	`NCT00344071` - Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia	N/A
Recruiting	`NCT05383196` - Onvansertib + Paclitaxel In TNBC	Phase 1/Phase 2
Active, not recruiting	`NCT02221999` - Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients	Phase 2/Phase 3
Completed	`NCT00003199` - Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer	Phase 2
Terminated	`NCT00016276` - Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer	Phase 3
Recruiting	`NCT01880385` - Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer	Phase 1
Not yet recruiting	`NCT06131632` - Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant Chemotherapy	N/A
Completed	`NCT00513695` - Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer	Phase 2
Completed	`NCT00340158` - Establishing an Inflammatory Breast Cancer Registry	N/A
Recruiting	`NCT04636710` - Refining Local-Regional Therapy for IBC	N/A
Active, not recruiting	`NCT05415215` - A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer	Phase 3
Recruiting	`NCT04030507` - Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer	N/A
Recruiting	`NCT03515798` - Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer	Phase 2
Completed	`NCT01583426` - Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)	Phase 3
Recruiting	`NCT02879513` - Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy	Phase 3
Completed	`NCT02199418` - Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer	Phase 2
Active, not recruiting	`NCT02623972` - A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer	Phase 2
Recruiting	`NCT00891280` - Dose-escalation Study of Oral CX-4945	Phase 1
Completed	`NCT00049114` - Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer	Phase 2
Active, not recruiting	`NCT04660929` - CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors	Phase 1

NCT number	NCT02324088
Study type	Interventional
Source	UNICANCER
Contact
Status	Completed
Phase	Phase 3
Start date	October 2000
Completion date	January 2015

Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer — PEGASE07

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms